Form 8-K - Current report:
SEC Accession No. 0001615774-18-001701
Filing Date
2018-03-08
Accepted
2018-03-08 17:00:37
Documents
2
Period of Report
2018-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s109270_8k.htm 8-K 17728
2 EXHIBIT 99.1 s109270_ex99-1.htm EX-99.1 11041
  Complete submission text file 0001615774-18-001701.txt   30165
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 18677262
SIC: 8731 Services-Commercial Physical & Biological Research